On 9 August, US health officials approved the first nasal spray to treat allergic reactions from drugmaker ARS Pharmaceuticals Inc, an alternative to injectable allergy medications like EpiPen. The ...

Neffy needle-free epinephrine spray sales surge, global expansion, and CSU Phase 2b upside. See more on SPRY here.

Aug. 26—Those at risk of a severe allergic reaction always have handy an EpiPen just in case. But soon their life might be saved by a spray in the nose rather than a needle to the thigh. Last week the ...

Five poster presentations highlight clinical advancement of neffy , real-world usability and advantages of needle-free epinephrine ...

The Food and Drug Administration approved a new nasal spray Friday as the first needle-free emergency treatment for potentially fatal allergic reactions. The spray, which is made by ARS ...

It felt good to be home, if only for one night: home, in this case, being my Tiny Desk at NPR. We were about to film Neffy, our 2021 Tiny Desk Contest winner, at my desk at NPR headquarters. My corner ...

These two biotechs only have one marketable therapy each, but both have blockbuster potential.

Good news for those who suffer from severe allergic reactions: a nasal spray containing epinephrine rather than a needle can now treat those frightening moments. The treatment, called Neffy, was ...

Credit: ARS Pharma. Neffy is supplied as a single-dose (2mg of epinephrine) nasal spray that is administered into 1 nostril. With regard to cardiovascular effects, increases in blood pressure and ...

FDA approves Neffy 1 mg for children aged 4+ weighing 15 to <30 kg for allergic reactions. Most insured patients can access Neffy for $25, while cash price is $199 for two doses. Get our list of 10 ...